Global Carotid Stents Market 2017-2021
About Carotid Stents
There are two carotid arteries, one on each side of the neck that supply blood to the brain. These arteries can get narrowed and damaged with time by fatty deposits called plaque. If the plaque breaks open, it might create a blood clot, which could impact the brain and cause a stroke. Carotid stenting can enhance the blood flow to the brain, lowering the risk of a stroke. CAS is a method that can be utilized to open a narrowed carotid artery. It involves the placement of a small, expandable tube called stent in the affected artery. This procedure can also be called carotid angioplasty and stenting.
Technavio’s analysts forecast the global carotid stents market to grow at a CAGR of 12.4% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global carotid stents market for 2017-2021. To calculate the market size, the report considers the sales/volume/value of carotid stents.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Carotid Stent Market 2017-2021
Technavio recognizes the following companies as the key players in the global carotid stents market: Abbott, Boston Scientific, Cardinal Health, Medtronic, and Terumo
Other Prominent Vendors in the market are: Balton, InspireMD, optimed, and W. L. Gore & Associates.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Increase in M&A. Companies are adopting M&A to expand their presence globally. They are also using this strategy to increase their product portfolio and market share. This strategy empowers organizations to juxtapose innovation with R&D abilities. The trade increases the opportunities for small organizations, as the larger organizations are constantly interested in acquiring them for their development prospects. M&A remain an important option for various medical device manufacturing companies.”
According to the report, one of the major drivers for this market is Global burden of vascular diseases and stroke. The number of people affected by vascular diseases and stroke is increasing globally. CVDs are the main cause of death across the globe. The burden of CVDs is more prominent in emerging countries than in developed countries. Stroke and TIA are also prevalent globally and are responsible for a large number of deaths.
Further, the report states that one of the major factors hindering the growth of this market is Availability of alternative therapies. The alternatives to carotid stents such as EECP, CEA, atherectomy, and laser angiography have been gaining popularity in the recent years. EECP is a procedure that can save lives and healthcare expenses. The technique allows increased blood flow to the heart, strengthens circulation, and offers better ways to treat heart diseases without the need for stents or bypass surgery.
Abbott, Boston Scientific, Cardinal Health, Medtronic, Terumo, Balton, InspireMD, optimed, and W. L. Gore & Associates.